Podiatrist, Foot & Ankle Surgery · Kenosha, WI
NPI
1821092420
Since 2005
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6123 Green Bay Rd, Ste 100
Kenosha, WI, 53142
Phone (262) 657-3668
Groups this clinician bills Medicare through
Medicare paid, 2024
$167K
3,225 services
Medicare patients, 2024
504
Average age 74
Drug cost, 2024
$80K
913 prescriptions
Company payments, 2025
$329
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John L Bostanche was code 99213 (office e&m - established), 850 times for 333 patients. In total John L Bostanche billed 3,225 services in 66 codes, and Medicare paid $167K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 850 | 333 | $54.45 | $46K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 818 | 73 | $0.77 | $631 |
| 99214 Office E&M - Established | Office | 294 | 204 | $82.61 | $24K |
| 11721 Nail Procedure | Office | 250 | 93 | $26.02 | $6,505 |
| 73630 X-ray - Lower Extremity | Office | 163 | 97 | $22.74 | $3,707 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 133 | 55 | $0.09 | $11.89 |
| 20604 Joint Injection | Office | 127 | 38 | $42.97 | $5,457 |
| 99203 Office E&M - New | Office | 73 | 73 | $66.74 | $4,872 |
| 99204 Office E&M - New | Office | 65 | 65 | $102.93 | $6,691 |
| 11042 Debridement | Office | 56 | 19 | $79.55 | $4,455 |
| 20550 Musculoskeletal | Office | 29 | 18 | $30.74 | $891 |
| 20606 Joint Injection | Office | 26 | 14 | $55.86 | $1,452 |
| 11750 Nail Procedure | Office | 25 | 16 | $86.72 | $2,168 |
| 73610 X-ray - Lower Extremity | Office | 24 | 15 | $24.86 | $597 |
| 64450 Musculoskeletal | Office | 14 | 13 | $50.73 | $710 |
By year: 2022 $154K for 2,870 services; 2023 $186K for 3,235 services; 2024 $167K for 3,225 services.
Medicare prescription drug claims, 2024
In 2024, the drug John L Bostanche prescribed most often to Medicare patients was Calcipotriene, with 175 prescriptions and refills. In total John L Bostanche wrote 913 Medicare prescriptions that cost $80K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcipotriene Generic | 175 | 176 | 111 | $42K |
| Ketoconazole Generic | 161 | 211 | 97 | $5,338 |
| Meloxicam Generic | 140 | 142 | 96 | $452 |
| Mupirocin Mupirocin Calcium | 112 | 115 | 65 | $20K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 68 | 68 | 48 | $464 |
| Cephalexin Generic | 53 | 53 | 30 | $324 |
| Azithromycin Generic | 45 | 45 | 40 | $150 |
| Methylprednisolone Generic | 32 | 32 | 24 | $194 |
| Ciclopirox Generic | 24 | 24 | 17 | $2,330 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 12 | Under 11 | $76.57 |
Brand drugs: 21 claims; generic drugs: 892 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John L Bostanche $329 ($329 in general payments such as food, travel and fees) from 8 companies. The largest payer was ANI Pharmaceuticals, Inc. with $84.31.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.